GTC is proud to present the 2nd Neurological Biomarkers Conference as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the biomarker field related to neuroscience. Topics of this conference include updates on biomarkers in Alzheimer's disease, CSF and blood-based biomarkers and imaging biomarkers. Biomarker data will also be presented in other specific neurological disorders such as Parkinson's, Huntington's, schizophrenia, frototemporal dementia and more. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:
March 20th
Plenary Keynote Session
March 21st-22nd
Breakout: Neurological Biomarkers
Updates on Biomarkers in Alzheimer's Disease
CSF / Blood-based Biomarkers
Imaging Biomarkers in Neuroscience
- PET
- MRI /fMRI
Biomarkers in Other Neurological Disorders
- Parkinson's
- Schizophrenia
- Huntington's
- Frototemporal Dementia
- Autism
- Stroke
Mar 22nd
General Session
Regulatory & Reimbursement Updates in Biomarker & Diagnostic Development
+ Panel Discussion
New Technologies & Novel Approaches to Biomarker Development
Companion Diagnostics Development & Partnering Strategies
+ Panel Discussion
The 2nd Neurological Biomarkers Conference will be running concurrently with the following tracks:
2nd Inflammatory & Immunological Biomarkers
Call for Papers!
To be considered for an oral presentation, please submit an abstract here by February 20, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract ASAP.
Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405 x102 or spex@gtcbio.com for more information.
Best Regards,
Organizing Committee
See you in San Francisco!